Antibody tools for the diagnostic use in the medical therapy...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S338000, C530S388800

Reexamination Certificate

active

07858329

ABSTRACT:
The invention relates to a method for determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not comprising determining the level of histone acetylation in the sample by use of an antibody capable of binding to acetylated histone, and classifying the disorder as to be treated with an HDAC inhibitor when the level of histone acetylation is significantly lower than that of a reference sample. The invention further relates to the diagnostic and prognostic use of specific antibodies and cell lines producing them.

REFERENCES:
patent: 7256013 (2007-08-01), Tamai et al.
patent: 7276234 (2007-10-01), Takahama et al.
patent: 7632507 (2009-12-01), Nakajima et al.
patent: 2004/0152871 (2004-08-01), Nakajima et al.
patent: 2004/0198959 (2004-10-01), Komatsu et al.
patent: 1050581 (2000-08-01), None
patent: 1 050 581 (2000-11-01), None
patent: 02021228.8 (2002-09-01), None
patent: 10-298101 (1998-11-01), None
patent: 10-298101 (1998-11-01), None
patent: 2001-501190 (2001-01-01), None
patent: 2001501190 (2001-01-01), None
patent: 9811920 (1998-03-01), None
patent: WO 98-11919 (1998-03-01), None
patent: 9936532 (1999-07-01), None
patent: WO 99/36532 (2000-11-01), None
patent: 02052007 (2002-07-01), None
patent: WO 02/052007 (2002-07-01), None
patent: WO 02/074962 (2002-09-01), None
Hoffmann et al. (Bioconjug. Chem. Jan.-Feb. 2001;12(1):51-5) (Abstract).
Merriam-Webster on-line definition of “derived”.
Ono et al. (J. Exp. Clin. Can. Res. 21(3):377-382 (Sep. 2002); Abstract).
Marquard et al. (APMIS 116:382-392 (2008)).
Butler L M et al “Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. US Apr. 2001, vol. 7, No. 4, pp. 962-970.
Marks Paul A et al: “Histone Deacetylases and Cancer: Causes and Therapies.” Nature Reviews Cancer, vol. 1, No. 3, Dec. 20, 2001, pp. 194-202.
White D A et al: “Preparation of Site-Specific Antibodies to Acetylated Histones” Methods: A Companion to Methods in Enzymology, Academic Press Inc., NY, vol. 19, 1999, pp. 417-424.
Bodey et al., “Human Cancer Detection and Immunotherapy with Conjugated and Non-Conjugated Monoclonal Antibodies”, AntiCancer Research, vol. 16 (1996), pp. 661-674.
Butler et al., “Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase”, Clinical Cancer Research, vol. 7, pp. 962-970, Apr. 2001.
Marks et al., “Histone Deacetytases and Cancer: Causes and Therapies”, Nature Reviews, vol. 1, pp. 194-202, Dec. 2001.
White et al., “Preparation of Site-Specific Antibodies to Acotylated Histones”, Methods, vol. 19, pp. 417-424, 1999.
Aherne et al., “Assays for the identification and evaluation of histone acetyltransferase inhibitors”, Methods, vol. 28, pp. 245-253, 2002.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibody tools for the diagnostic use in the medical therapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody tools for the diagnostic use in the medical therapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody tools for the diagnostic use in the medical therapy... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4195044

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.